首页> 外文期刊>Current opinion in rheumatology >Bacteria and human autoimmunity: the case of primary biliary cirrhosis.
【24h】

Bacteria and human autoimmunity: the case of primary biliary cirrhosis.

机译:细菌和人类自身免疫:原发性胆汁性肝硬化。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE OF REVIEW: Primary biliary cirrhosis is a chronic inflammatory disease of the intrahepatic bile ducts that eventually leads to liver cirrhosis and organ failure, in which several observations suggest an autoimmune origin. Similarly to other autoimmune diseases, microbial mediated molecular mimicry is the most widely studied trigger that may break immunologic tolerance in primary biliary cirrhosis. RECENT FINDINGS: The hypothesis of a bacterial role in the cause of primary biliary cirrhosis has received recent attention, based on in vitro data and the identification of a unique xenobiotic-metabolizing bacterium that modulates naturally occurring environmental estrogens, namely, Novosphingobium aromaticivorans. SUMMARY: The evidence indicates that bacteria, through different mechanisms, may precipitate autoimmunity in primary biliary cirrhosis and other autoimmune diseases. These data have several implications.
机译:审查的目的:原发性胆汁性肝硬化是肝内胆管的一种慢性炎性疾病,最终导致肝硬化和器官衰竭,其中一些观察结果提示自身免疫性起源。与其他自身免疫性疾病类似,微生物介导的分子模拟是最广泛研究的触发因素,它可能会破坏原发性胆汁性肝硬化的免疫耐受性。最近的发现:基于体外数据和一种独特的异源代谢代谢细菌的鉴定,该细菌在原发性胆汁性肝硬化的病因中起作用的假说最近受到了关注,该细菌可调节天然存在的环境雌激素,即香豆新孢子虫。摘要:证据表明细菌可以通过不同的机制促进原发性胆汁性肝硬化和其他自身免疫性疾病的自身免疫。这些数据有几个含义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号